1 5
Analyzers

MedPlus

BD Veritor Plus Analyzer – Digital CLIA‑Waived Immunoassay Reader (BEC 256066)

BD Veritor Plus Analyzer – Digital CLIA‑Waived Immunoassay Reader (BEC 256066)

$339.00 USD
$379.00 USD $339.00 USD
Sale Sold out

⚠️ Back Order Estimated Restock Date:

Item Number

BEC 256066

Brand Name

BD

Order Packaging

1 Each

Vendor Shipping & Returns

MedPlus Shipping Policy:
$15.00 Flat Rate in Continental USA. Exclusions apply.

MedPlus Return Policy:
No Cancellations; No Returns; All Sales Final. Exclusions may apply.
All returns must be approved by our Returns Department. An e-mail notification will be issued regarding your return status and return instructions, should this apply. Any product returned for credit without an authorized RMA number clearly printed on the outside package or shipping label will be refused. Unauthorized returns will not be honored or accepted for credit.

View full details

Veritor Plus Analyzer (Non-Returnable) (Continental US Only)

The BD Veritor Plus System is a handheld device that enables testing for COVID-19 (SARS-CoV-2), Flu A+B, Group A Strep, and respiratory syncytial virus (RSV) assays. One-button functionality and workflow flexibility allow the healthcare team to confidently use the device. In addition, the system’s fast and accurate results may help improve the patient experience. The BD Veritor Plus System streamlines the point-of-care testing experience.

The BD Veritor™ Plus System

The BD Veritor™ Plus Analyzer provides reliable results in a timely manner, allowing you to quickly diagnose and treat your patients using an easy-to-read, portable device. Once you have bought the device, you can choose from a range of assays for a menu of respiratory tract infections.

Designed With You in Mind

The BD Veritor Plus System provides diagnostic testing where and when your patients need it, offering reliable, rapid results for a variety of respiratory tract infections.


Clock icon

Efficient

Small, convenient instruments for timely results for point of care testing


Content Card Image

Reliable

Results you can count on, with options that can help with result traceability.


Adaptable

Adaptable

Workflow options that are flexible to your needs and grow as demand increases.

Clinical performance vs RT-PCR

 

PPA

NPA

Results in

SARS-CoV-2

86.7%

(95% CI, 75.8%-93.1%)

99.5%

(95% CI, 97.4%-99.9%)

 

15 minutes

 

Influenza A

82.7%

(95% CI, 74.9%-88.5%)

97.5%

(95% CI, 95.7%-98.5%)

15 minutes

Influenza B

80.7%

(95% CI, 70.3%-88.1%)

98.2%

(95% CI, 95.7%-99.3%)

15 minutes

 

SARS-CoV-2, Flu A and Flu B* results in 15 minutes

NPA=negative percent agreement; PPA=positive percent agreement.

Ordering information

Cat no.

Qty

BD Veritor™ Plus System SARS-CoV-2 & Flu A+B kit*

256088

30 tests

BD Veritor™ Plus Analyzer

256066

1 unit

 

 

 BD Product No. Product Description Quantity
256066 BD Veritor™ Plus Analyzer 1 unit
256088 BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B 30 tests
256082 BD Veritor™ System for Rapid Detection of SARS-CoV-2  30 tests
256045 BD Veritor™ System for Rapid Detection of Flu A+B  30 tests
256041 BD Veritor™ System for Rapid Detection of Flu A+B (moderately complex)  30 tests
256038 BD Veritor™ System for Rapid Detection of RSV  30 tests
256042 BD Veritor™ System for Rapid Detection of RSV (moderately complex)  30 tests
256040 BD Veritor™ System for Rapid Detection of Group A Strep  30 tests
445010 BD Veritor™ InfoWiFi Module  1 unit
443907 USB Printer Cable  1 unit